NIDA National Drug Abuse Treatment Clinical Trials Network (CA-AZ Node)

UCSF leads the California-Arizona Research Node of the NIDA National Drug Abuse Treatment Clinical Trials Network (CTN). The overall goal of the Research Node is to participate in and conduct high-quality multi-site clinical trials of interventions for drug abuse and addiction, and to guide the development, dissemination, and adoption of effective interventions in the field.  The Research Node consists of a Regional Research and Training Center (RRTC) at UCSF that is linked in partnership with researchers at the University of Arizona and with twenty community-based treatment programs (CTPs) in California and Arizona.  The goal of the CA-AZ Research Node is to stimulate research to improve the effectiveness of treatment of addiction to opiates, cocaine and methamphetamine, nicotine, and other abused drugs. The gap between research and treatment is one of the most critical unresolved issues in drug abuse. The Node fosters collaboration among scientists and practitioners to stimulate new research improving the effectiveness of drug abuse treatment in community settings.

UCSF Investigators

University of Arizona Investigators

Key Staff

Community Treatment Programs (CTPs)

Allied Programs

Implementation Partners

Contact

James L. Sorensen, PhD, Principal Investigator Director of the California-Arizona CTN Node
University of California, San Francisco
San Francisco General Hospital
1001 Potrero Avenue
Building 20, Suite 2117, Box 0852
San Francisco, CA 94110
415-206-3969

Principal Investigators


 

Leadership in research, education, psychiatric care and public service